← All organizations
First marketed drug
Dec 13, 2017Last known activity
Mar 6, 2026
Timeline
2010s
- Jan 1, 2013
Mallinckrodt (2013)— Founded
- Jan 1, 2013
CNS Therapeutics— Acquired
- Jan 1, 2014
Cadence Pharmaceuticals— Acquired
- Jan 1, 2014
Questcor Pharmaceuticals— Acquired
- Jan 1, 2015
Ikaria— Acquired
- Jan 1, 2015
Therakos— Acquired
- Aug 10, 2016
Stratatech Corporation— Acquired
- Aug 4, 2017
InfaCare Pharmaceuticals Corporation— Acquired
- Nov 2, 2017
Ocera Therapeutics— Acquired
- Dec 1, 2017
Specgx Llc— Acquired
- Dec 26, 2017
Sucampo— Acquired
- Dec 13, 2019
levorphanol tartrate— Marketing Organization
2020s
- Jun 15, 2021
Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen— NDA Secondary Org
- Mar 1, 2025
Endo Pharmaceuticals— Acquired
Drugs by trial phase (148 distinct, 373 trials)
Phase 4 (0 own, 20 via acquisition)
Phase 3 (0 own, 40 via acquisition)
Phase 2 (0 own, 42 via acquisition)
Marketed drugs (12)
Subsidiaries (11 direct, 38 total across the full acquisition tree)
- Cadence Pharmaceuticals
- CNS Therapeutics
- Endo Pharmaceuticals
- Ikaria
- InfaCare Pharmaceuticals Corporation
- Ocera Therapeutics
- Questcor Pharmaceuticals
- Specgx Llc
- Stratatech Corporation
- Sucampo
- Therakos
- American Medical Systems L2
- Auxillium L2
- Biospecifics Technologies Corp. L2
- Boca Pharmacal L2
- DAVA Pharmaceuticals L2
- Indevus Pharmaceuticals L2
- INO Therapeutics L2
- NuPathe Inc. L2
- Paladin Labs L2
- Par Pharmaceuticals L2
- Penwest Pharmaceuticals Co. L2
- R-Tech Ueno L2
- RxKinetix L2
- Somar L2
- Somerset Therapeutics LLC L2
- Tranzyme, Inc. L2
- Vtesse Inc. L2
- Wintac Limited L2
- Actient L3
- Allon Therapeutics L3
- Anchen Pharmaceuticals, Inc L3
- Ethics Bio Lab L3
- JHP Pharmaceuticals LLC L3
- Labopharm L3
- Moderna Therapeutics L3
- VIRexx L3
- Slate Pharmaceuticals L4
Details
- Founded
- St Louis, MO, US Jan 1, 2013
- Last known activity
- Mar 6, 2026
Notes
Spun out from Covidien in 2013